Atlas Trials

A Relative Bioavailability Study of Different Processes of SHR2554 Tablets in Healthy Adult Subjects

Clinical trial NCT05049083 · UNKNOWN

Trial details

NCT number
NCT05049083
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Lymphoma
Start date
2021-12-17
Primary completion
2022-01-06
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.